Mari Terada

1.3k total citations
33 papers, 423 citations indexed

About

Mari Terada is a scholar working on Infectious Diseases, Neurology and Oncology. According to data from OpenAlex, Mari Terada has authored 33 papers receiving a total of 423 indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Infectious Diseases, 15 papers in Neurology and 8 papers in Oncology. Recurrent topics in Mari Terada's work include COVID-19 Clinical Research Studies (26 papers), Long-Term Effects of COVID-19 (15 papers) and SARS-CoV-2 and COVID-19 Research (10 papers). Mari Terada is often cited by papers focused on COVID-19 Clinical Research Studies (26 papers), Long-Term Effects of COVID-19 (15 papers) and SARS-CoV-2 and COVID-19 Research (10 papers). Mari Terada collaborates with scholars based in Japan, Belgium and United States. Mari Terada's co-authors include Norio Ohmagari, Shinya Tsuzuki, Kayoko Hayakawa, Sho Saito, Shinichiro Morioka, Satoshi Kutsuna, Yusuke Miyazato, Keiko Tanaka, Michiyo Suzuki and Yusuke Asai and has published in prestigious journals such as Scientific Reports, International Journal of Epidemiology and BMJ Open.

In The Last Decade

Mari Terada

29 papers receiving 416 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mari Terada Japan	10	252	247	106	42	40	33	423
Mohammad Raza Pakistan	8	143 0.6×	113 0.5×	112 1.1×	49 1.2×	49 1.2×	29	367
Jesus Alfonso Catahay United States	9	379 1.5×	331 1.3×	151 1.4×	35 0.8×	18 0.5×	16	623
Bojan Hartmann Germany	8	259 1.0×	338 1.4×	144 1.4×	39 0.9×	69 1.7×	13	517
Seow Yen Tan Singapore	8	326 1.3×	163 0.7×	51 0.5×	46 1.1×	21 0.5×	19	461
Abbygail Therese Ver Philippines	10	435 1.7×	442 1.8×	207 2.0×	52 1.2×	23 0.6×	13	759
Charalampos D. Moschopoulos Greece	8	202 0.8×	113 0.5×	40 0.4×	52 1.2×	18 0.5×	21	361
Aliaë Mohamed-Hussein Egypt	12	116 0.5×	128 0.5×	54 0.5×	43 1.0×	26 0.7×	48	410
Shengyan Zhang China	6	375 1.5×	212 0.9×	40 0.4×	25 0.6×	75 1.9×	11	498
Marnar Fríðheim Kristiansen Faroe Islands	11	249 1.0×	294 1.2×	155 1.5×	15 0.4×	44 1.1×	19	479
Ciarán Bannan Ireland	13	291 1.2×	425 1.7×	174 1.6×	104 2.5×	38 0.9×	20	711

Countries citing papers authored by Mari Terada

Since Specialization

Citations

This map shows the geographic impact of Mari Terada's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mari Terada with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mari Terada more than expected).

Fields of papers citing papers by Mari Terada

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mari Terada. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mari Terada. The network helps show where Mari Terada may publish in the future.

Co-authorship network of co-authors of Mari Terada

This figure shows the co-authorship network connecting the top 25 collaborators of Mari Terada. A scholar is included among the top collaborators of Mari Terada based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mari Terada. Mari Terada is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Kim, Jeeeun, Yasuhiro Irino, Masayuki Amano, et al.. (2025). A high-throughput, fully automated competition assay to evaluate SARS-CoV-2 neutralizing responses and epitope specificity in clinical samples. Scientific Reports. 15(1). 11589–11589.

Iwamoto, Noriko, Yuki Takamatsu, Yusuke Asai, et al.. (2024). High diagnostic accuracy of quantitative SARS-CoV-2 spike-binding-IgG assay and correlation with in vitro viral neutralizing activity. Heliyon. 10(2). e24513–e24513. 2 indexed citations

Nakakubo, Sho, Koji Kitajima, Mari Terada, et al.. (2023). Serum Lactate Dehydrogenase Level One Week after Admission Is the Strongest Predictor of Prognosis of COVID-19: A Large Observational Study Using the COVID-19 Registry Japan. Viruses. 15(3). 671–671. 6 indexed citations

Suzuki, Michiyo, Kayoko Hayakawa, Yusuke Asai, et al.. (2023). Characteristics of hospitalized COVID-19 patients with other respiratory pathogens identified by rapid diagnostic test. Journal of Infection and Chemotherapy. 29(5). 539–545. 1 indexed citations

Morioka, Shinichiro, Shinya Tsuzuki, Mari Terada, et al.. (2023). Epidemiology of post-COVID conditions beyond 1 year: a cross-sectional study. Public Health. 216. 39–44. 23 indexed citations

Matsunaga, Nobuaki, Yusuke Asai, Shinya Tsuzuki, et al.. (2022). Predictive model of risk factors of High Flow Nasal Cannula using machine learning in COVID-19. Infectious Disease Modelling. 7(3). 526–534. 4 indexed citations

Tsuzuki, Shinya, Yusuke Miyazato, Mari Terada, et al.. (2022). Impact of long-COVID on health-related quality of life in Japanese COVID-19 patients. Health and Quality of Life Outcomes. 20(1). 125–125. 36 indexed citations

Ishikane, Masahiro, Mari Terada, Akihiro Matsunaga, et al.. (2022). Antibody responses after two doses of SARS-CoV-2 mRNA-1273 vaccine in an individual with history of COVID-19 re-infection. International Journal of Infectious Diseases. 119. 18–20.

Matsushita, Yumi, Tetsuji Yokoyama, Kayoko Hayakawa, et al.. (2022). We Should Pay More Attention to Sex Differences to Predict the Risk of Severe COVID-19: Men Have the Same Risk of Worse Prognosis as Women More Than 10 Years Older. Journal of Epidemiology. 33(1). 38–44. 1 indexed citations

10.

Miyazato, Yusuke, Shinya Tsuzuki, Shinichiro Morioka, et al.. (2022). Factors associated with development and persistence of post-COVID conditions: A cross-sectional study. Journal of Infection and Chemotherapy. 28(9). 1242–1248. 16 indexed citations

11.

Asai, Yusuke, Hidetoshi Nomoto, Kayoko Hayakawa, et al.. (2022). Comorbidities as Risk Factors for Severe Disease in Hospitalized Elderly COVID-19 Patients by Different Age-Groups in Japan. Gerontology. 68(9). 1027–1037. 24 indexed citations

12.

Yoshihara, Fumiki, Hiroshi Ohtsu, Michikazu Nakai, et al.. (2022). Renin-angiotensin system blocker and the COVID-19 aggravation in patients with hypertension, diabetes, renal failure, Cerebro-cardiovascular disease, or pulmonary disease: Report by the COVID-19 Registry Japan. Journal of Cardiology. 80(4). 292–297. 2 indexed citations

13.

Asai, Yusuke, Kayoko Hayakawa, Satoshi Kutsuna, et al.. (2022). Comparison of the clinical characteristics and outcomes of Japanese patients with COVID-19 treated in primary, secondary, and tertiary care facilities. Journal of Infection and Chemotherapy. 29(3). 302–308. 2 indexed citations

14.

Nomoto, Hidetoshi, Satoshi Kutsuna, Kazu Okuma, et al.. (2021). No SARS-CoV-2 RNA detected in the convalescent plasma of COVID-19 patients with different disease severity. Journal of Infection and Chemotherapy. 27(4). 653–655. 2 indexed citations

15.

Ishikane, Masahiro, Mari Terada, Akihiro Matsunaga, et al.. (2021). Asymptomatic COVID-19 re-infection in a Japanese male by elevated half-maximal inhibitory concentration (IC50) of neutralizing antibodies. Journal of Infection and Chemotherapy. 27(7). 1063–1067. 7 indexed citations

16.

Yamada, Gen, Kayoko Hayakawa, Nobuaki Matsunaga, et al.. (2021). Predicting respiratory failure for COVID-19 patients in Japan: a simple clinical score for evaluating the need for hospitalisation. Epidemiology and Infection. 149. e175–e175. 11 indexed citations

17.

Hara, Hisao, Yukari Uemura, Kayoko Hayakawa, et al.. (2021). Evaluation of the efficacy of anticoagulation therapy in reducing mortality in a nationwide cohort of hospitalized patients with coronavirus disease in Japan. International Journal of Infectious Diseases. 112. 111–116. 2 indexed citations

18.

Kutsuna, Satoshi, Yusuke Asai, Akihiro Matsunaga, et al.. (2021). Factors associated with anti-SARS-CoV-2 IgG antibody production in patients convalescing from COVID-19. Journal of Infection and Chemotherapy. 27(6). 808–813. 14 indexed citations

19.

Yamada, Gen, Kayoko Hayakawa, Yusuke Asai, et al.. (2021). External validation and update of prediction models for unfavorable outcomes in hospitalized patients with COVID-19 in Japan. Journal of Infection and Chemotherapy. 27(7). 1043–1050. 4 indexed citations

20.

Kobayakawa, Masao, Mari Terada, Hiroshi Ohtsu, et al.. (2018). <b>Attempt to Develop Japanese Translation of “NIH and FDA Release Protocol Template for Phase 2 and 3 IND/IDE Clinical Trials” </b>. Rinsho yakuri/Japanese Journal of Clinical Pharmacology and Therapeutics. 49(1). 35–38.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact